Experienced in Pure Red Cell Aplasia

Dr. Elias J. Sayour

Pediatric Hematology Oncology
1600 Sw Archer Rd, 
Gainesville, FL 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Pure Red Cell Aplasia
1600 Sw Archer Rd, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elias Sayour is a Pediatric Hematologist Oncology provider in Gainesville, Florida. Dr. Sayour is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Glioma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Brain Stem Cancer.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pure Red Cell Aplasia.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Florida Blue
  • EPO
  • PPO

Locations

1600 Sw Archer Rd, Gainesville, FL 32610

Additional Areas of Focus

Dr. Sayour has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PEACH TRIAL- Precision mEdicine and Adoptive Cellular tHerapy for the Treatment of Recurrent Neuroblastoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
PEACH TRIAL- Precision mEdicine and Adoptive Cellular tHerapy for the Treatment of Recurrent Neuroblastoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Biological
Study Drug: Tumor-Specific Ex Vivo Expanded Autologous Lymphocyte Transfer (TTRNA-xALT)
Study Phase: Phase 1
ACTION Trial: Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I).
ACTION Trial: Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I).
Enrollment Status: Terminated
Publish Date: October 02, 2025
Intervention Type: Drug, Biological
Study Drugs: TTRNA-DC Vaccines with GM-CSF, Dose-Intensified TMZ, Autologous Hematopoietic Stem Cells (HSCs), TTRNA-xALT, Td Vaccine
Study Phase: Phase 1
BRAVO: Newly-Diagnosed Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Recovery From Focal Radiotherapy Alone or Focal Radiotherapy and Dose-intensified Temozolomide (Phase I)
BRAVO: Newly-Diagnosed Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Recovery From Focal Radiotherapy Alone or Focal Radiotherapy and Dose-intensified Temozolomide (Phase I)
Enrollment Status: Terminated
Publish Date: August 06, 2025
Intervention Type: Biological, Drug
Study Drugs: TTRNA-DC vaccines with GM-CSF, TTRNA-xALT, Cyclophosphamide, Fludarabine Lymphodepletive Conditioning, Dose-Intensified TMZ, Td vaccine, Autologous Hematopoietic Stem Cells
Study Phase: Phase 1
A Target Validation Study of Fimepinostat in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG), Recurrent Medulloblastoma, or Recurrent High-Grade Glioma (HGG)
A Target Validation Study of Fimepinostat in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG), Recurrent Medulloblastoma, or Recurrent High-Grade Glioma (HGG)
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Drug, Procedure
Study Drug: Fimepinostat
Study Phase: Early Phase 1
View 3 Less Clinical Trials

60 Total Publications

Blocking immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response.
Blocking immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response.
Journal: The Journal of clinical investigation
Published: July 01, 2025
Similar Doctors
Experienced in Pure Red Cell Aplasia
Dr. Manisha M. Bansal
Pediatric Hematology Oncology
Experienced in Pure Red Cell Aplasia
Dr. Manisha M. Bansal
Pediatric Hematology Oncology
807 Childrens Way, 
Jacksonville, FL 
 (61.8 miles away)
904-390-3600
Languages Spoken:
English
See accepted insurances

Manisha Bansal is a Pediatric Hematologist Oncology provider in Jacksonville, Florida. Dr. Bansal is rated as a Distinguished provider by MediFind in the treatment of Pure Red Cell Aplasia. Her top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Acute Lymphoblastic Leukemia (ALL), and Hemoglobinopathy.

Experienced in Pure Red Cell Aplasia
Dr. Michael J. Joyce
Pediatric Hematology Oncology
Experienced in Pure Red Cell Aplasia
Dr. Michael J. Joyce
Pediatric Hematology Oncology
807 Childrens Way, 
Jacksonville, FL 
 (61.8 miles away)
904-390-3789
Languages Spoken:
English
See accepted insurances

Michael Joyce is a Pediatric Hematologist Oncology provider in Jacksonville, Florida. Dr. Joyce is rated as an Advanced provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, Sickle Cell Disease, and Bone Marrow Transplant.

Experienced in Pure Red Cell Aplasia
Dr. Eric S. Sandler
Pediatric Hematology Oncology
Experienced in Pure Red Cell Aplasia
Dr. Eric S. Sandler
Pediatric Hematology Oncology
807 Childrens Way, 
Jacksonville, FL 
 (61.8 miles away)
904-390-3600
Languages Spoken:
English
See accepted insurances

Eric Sandler is a Pediatric Hematologist Oncology provider in Jacksonville, Florida. Dr. Sandler is rated as an Advanced provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Brain Stem Cancer, Acute Lymphoblastic Leukemia (ALL), Medulloblastoma, and Glioma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sayour's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile